Geneva Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
14,479
-483
| -3% | -$37.8K | 0.02% | 122 |
|
|
2025
Q1 | $1.08M | Sell |
14,962
-268
| -2% | -$19.4K | 0.02% | 123 |
|
|
2024
Q4 | $1.13M | Sell |
15,230
-1,092
| -7% | -$80.8K | 0.02% | 128 |
|
|
2024
Q3 | $1.08M | Sell |
16,322
-1,415
| -8% | -$93.4K | 0.02% | 129 |
|
|
2024
Q2 | $1.64M | Sell |
17,737
-4,421
| -20% | -$408K | 0.03% | 125 |
|
|
2024
Q1 | $2.12M | Sell |
22,158
-1,104
| -5% | -$105K | 0.04% | 120 |
|
|
2023
Q4 | $1.77M | Sell |
23,262
-1,165
| -5% | -$88.8K | 0.03% | 121 |
|
|
2023
Q3 | $1.69M | Sell |
24,427
-9,378
| -28% | -$650K | 0.04% | 120 |
|
|
2023
Q2 | $3.19M | Sell |
33,805
-1,423
| -4% | -$134K | 0.06% | 111 |
|
|
2023
Q1 | $2.91M | Sell |
35,228
-2,622
| -7% | -$217K | 0.06% | 112 |
|
|
2022
Q4 | $2.82M | Buy |
37,850
+1,289
| +4% | +$96.2K | 0.06% | 114 |
|
|
2022
Q3 | $3.02M | Sell |
36,561
-12
| -0% | -$992 | 0.07% | 116 |
|
|
2022
Q2 | $3.48M | Sell |
36,573
-403
| -1% | -$38.3K | 0.08% | 112 |
|
|
2022
Q1 | $4.35M | Buy |
36,976
+420
| +1% | +$49.4K | 0.08% | 113 |
|
|
2021
Q4 | $4.74M | Sell |
36,556
-893
| -2% | -$116K | 0.08% | 114 |
|
|
2021
Q3 | $4.24M | Sell |
37,449
-1,083
| -3% | -$123K | 0.07% | 114 |
|
|
2021
Q2 | $3.99M | Sell |
38,532
-167
| -0.4% | -$17.3K | 0.07% | 115 |
|
|
2021
Q1 | $3.24M | Buy |
38,699
+4,529
| +13% | +$379K | 0.06% | 119 |
|
|
2020
Q4 | $3.12M | Buy |
34,170
+36
| +0.1% | +$3.28K | 0.05% | 120 |
|
|
2020
Q3 | $2.73M | Buy |
34,134
+309
| +0.9% | +$24.7K | 0.06% | 116 |
|
|
2020
Q2 | $2.34M | Buy |
33,825
+300
| +0.9% | +$20.7K | 0.05% | 115 |
|
|
2020
Q1 | $2.11M | Buy |
+33,525
| New | +$2.11M | 0.06% | 115 |
|
|
2013
Q4 | – | Sell |
-3,055,296
| Closed | -$35.5M | – | 137 |
|
|
2013
Q3 | $35.5M | Sell |
3,055,296
-1,329,936
| -30% | -$15.4M | 0.84% | 55 |
|
|
2013
Q2 | $49.1M | Buy |
+4,385,232
| New | +$49.1M | 0.98% | 51 |
|